|
TMEM136 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25389999999326E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51699999999733E-05 |
| Normal-vs-Stage2 |
1.462910E-03 |
| Normal-vs-Stage3 |
2.657900E-03 |
| Normal-vs-Stage4 |
5.610800E-04 |
| Stage1-vs-Stage2 |
9.724600E-01 |
| Stage1-vs-Stage3 |
2.312400E-01 |
| Stage1-vs-Stage4 |
8.378600E-01 |
| Stage2-vs-Stage3 |
3.878000E-01 |
| Stage2-vs-Stage4 |
9.070800E-01 |
| Stage3-vs-Stage4 |
2.789000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.69870000000283E-05 |
| Normal-vs-AfricanAmerican |
2.17039999999002E-05 |
| Normal-vs-Asian |
4.910600E-01 |
| Caucasian-vs-AfricanAmerican |
1.432430E-02 |
| Caucasian-vs-Asian |
4.765600E-01 |
| AfricanAmerican-vs-Asian |
1.534370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.621800E-04 |
| Normal-vs-Female |
7.59359999991105E-07 |
| Male-vs-Female |
4.196800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.209700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.239840E-04 |
| Normal-vs-Age(61-80Yrs) |
8.33380000000439E-05 |
| Normal-vs-Age(81-100Yrs) |
2.763200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.408000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.435800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.040000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.494000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.026600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.925800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.10540000000248E-05 |
| Normal-vs-Grade 2 |
2.15189999999144E-05 |
| Normal-vs-Grade 3 |
1.220100E-03 |
| Normal-vs-Grade 4 |
1.035080E-03 |
| Grade 1-vs-Grade 2 |
7.499500E-03 |
| Grade 1-vs-Grade 3 |
7.443600E-03 |
| Grade 1-vs-Grade 4 |
8.213900E-02 |
| Grade 2-vs-Grade 3 |
3.595400E-01 |
| Grade 2-vs-Grade 4 |
6.451400E-01 |
| Grade 3-vs-Grade 4 |
2.851000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.53690000000073E-05 |
| Normal-vs-ccB subtype |
6.381000E-04 |
| ccA subtype-vs-ccB subtype |
8.617400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43479999999919E-05 |
| Normal-vs-N1 |
4.130800E-01 |
| N0-vs-N1 |
1.905380E-01 |
|
|
